Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel nickel-catalyzed route for Upadacitinib intermediates reduces precious metal usage and enhances purity for reliable pharmaceutical supply chains.
Patent CN108658786B details a novel extraction method reducing impurities significantly. This ensures compliant API production with lower costs and enhanced supply chain reliability for global buyers.
Patent CN113481181B details a novel esterase mutant for resolving indoline derivatives, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Novel safe synthesis route for 5-phenyl tetrazole intermediates reduces explosion risks and improves yield for pharmaceutical supply chains globally.
Patent CN103664577A reveals a novel method for Cinacalcet intermediate synthesis, offering safer conditions and higher purity for pharmaceutical supply chains.
Patent CN103360287B enables high-purity pharmaceutical intermediates via selective oxidation. Reduces waste and enhances supply chain reliability for global buyers.
Patent CN109609536B reveals efficient whole-cell synthesis. Reduces cost and improves supply chain reliability for high-purity L-carnosine manufacturing.
Patent CN109609536B enables efficient L-carnosine production. Reduced costs and enhanced supply chain reliability for pharmaceutical intermediates.
Patent CN108178761A reveals a mild PtO2 catalytic route for Sitagliptin. This method offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN1468212A introduces a safe, cost-effective asymmetric cyanation method using alkali metal cyanides and chiral titanium catalysts for high-purity pharmaceutical intermediates.
Patent CN115896060A reveals a novel ω-transaminase mutant for silodosin synthesis, offering >99% ee and scalable biocatalysis for reliable supply chains.
Patent CN103360410B details a novel trimethylchlorosilane protection route enhancing yield and purity for scalable Ofloxacin USP 23 manufacturing supply chains.
Patent CN103555608B reveals high-efficiency biocatalytic route for chiral intermediate. Enables cost reduction and supply chain reliability for pharma.
Novel preparation method for Gadoxetate disodium intermediate offering high purity and industrial scalability for pharmaceutical supply chains globally.
Patent CN112143688A reveals a novel recombinant E. coli strain for high-purity (S)-CHBE production, offering significant cost reduction in API manufacturing.
Advanced synthesis of bis-aziridine amino acids via patent CN113061111A. Streamlined route reduces costs and enhances supply chain reliability for biological probes.
Patent CN110483440A reveals a mild three-step route for high-purity thiazole intermediates. This process offers significant supply chain stability and cost optimization for pharmaceutical manufacturing.
Patent CN113583992A reveals a novel RsRedAm enzyme for efficient secondary amine synthesis, offering mild conditions and high selectivity for pharmaceutical intermediates.
Patent CN110382705B details a novel enzymatic route for L-Alanyl-L-Glutamine using engineered acyltransferase, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Novel fragment condensation method reduces racemization. Reliable semaglutide supplier offering cost-effective manufacturing solutions.